The best advertising is free
Executive Summary
PhRMA defends "Pray for a Miracle" ad campaign in response to Sept. 20 letter from Generic Pharmaceutical Association (1"The Pink Sheet" Sept. 23, In Brief). "The ad accurately points out that the legislation you champion would reduce incentives for the discovery of new medicine," PhRMA President Alan Holmer told GPhA in a Sept. 24 letter. "Generic drugs will offer nothing to those patients whose chances for a cure would decline if that legislation were to pass"...
You may also be interested in...
PhRMA’s prayer is answered
Generic Pharmaceutical Association urges Pharmaceutical Research & Manufacturers of America to discontinue ad campaign entitled "Pray For A Miracle." Ad "shamelessly exploits the photograph of a critically ill child" and "serves no purpose in advancing the debate regarding Hatch/Waxman," GPhA says in Sept. 20 letter to PhRMA. Ad ran in the Washington Post Sept. 18...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.